The market potential of the European biotechnology and pharmaceutical sector is enormous and business opportunities abound. However, unraveling the maze of who’s who, and who does what is a daunting task. Here’s the solution you’ve been looking for . . .

The new edition of The European Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date guide to Europe’s ever-changing pharmaceutical industry.

If you need to source from, or sell to Europe’s Pharmaceuticals, Biotechnology products, Biopharmaceuticals, Bulk Pharmaceuticals, OTC/Healthcare products, Research & Development, Fine Chemicals, Generics, Genomics, or Diagnostics/Reagents; or, if you’re looking to break into this appealing market, the new European Pharmaceutical Directory will provide you with thousands of fresh business contacts – and help you keep track of old ones – quickly and easily.

This one directory covers the entire European pharmaceutical & biotechnology industry sector.

This Directory will enable you to:

• Profile a market
• Build new business prospects
• Pinpoint key executives
• Generate new customers
• Discover who your competitors are
• Make vital contacts
• Save the time, money and effort of doing your own research
• Identify alternative suppliers and manufacturers
• Source up-to-date company information
• Access a wealth of quality information on healthcare companies.

Whether you are a product manager, in charge of marketing or simply interested to remain in touch with the latest developments in the European pharmaceutical industry, this Directory will save you time and effort in finding the up-to-date information you need.

For just US$350.00 The European Pharmaceutical Directory gives you instant access to a wealth of accurate contact information on over 5000 companies in Austria, Belarus, Belgium, Bosnia, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, the Slovak Republic, Slovenia, Spain, Sweden, Switzerland, the Ukraine, and the United Kingdom.

Look at the depth of information you’ll get in the European Pharmaceutical Directory:

• Full company contact details.
• Web and Email addresses.
• Names of key management and trading personnel.
• Locations of offices, sales offices and overseas sales agencies.
• Company activities.

6 Great Reasons to order your copy of The European Pharmaceutical Directory:

1. Save time: no need to search the internet, all the information you need is in one handy guide;
2. Save money: by using a resourceful book that details all your business contacts activities;
3. Gain an understanding of the key players in this increasingly dominant market: quickly and easily
4. Source the right trader/producer: by identifying products quickly;
5. Discover new business leads: and grow your business;
6. Update your contact list: from the most reliable source in the industry.

Why wait? If you’re are buying or selling pharmaceuticals into the European market, or wishing to do so, this directory is essential for you. Where else will you find such a broad depth of both key contact and production information for the European pharmaceutical industry in one handy reference source?

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1169/European-Pharmaceutical-Directory-2010.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Keep up-to-date with the Asian Pharmaceutical Industry and discover thousands of new business leads with this the top source of information on 10,000 pharmaceutical and biotechnology companies throughout Asia!

The market potential of the Asian pharmaceutical and biotechnology sector is enormous and business opportunities abound. However, unraveling the maze of who’s who, and who does what is a daunting task. Here’s the solution you’ve been looking for…

This new edition of The Asian Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date guide to Asia’s ever-changing pharmaceutical industry.

If you need to source from, or sell to Pharmaceuticals, Biotechnology products, Biopharmaceuticals, Bulk Pharmaceuticals, OTC/Healthcare products, Research & Development, Fine Chemicals, Generics, Genomics, or Diagnostics/Reagents; or, if you’re looking to break into this appealing market, the new Asian Pharmaceutical Directory will provide you with thousands of fresh business contacts – and help you keep track of old ones – quickly and easily.

This one directory covers the entire Asian pharmaceutical & biotechnology industries sector.

This Directory will enable you to:

• Profile a market
• Build new business prospects
• Pinpoint key executives
• Generate new customers
• Discover who your competitors are
• Make vital contacts
• Save the time, money and effort of doing your own research
• Identify alternative suppliers and manufacturers
• Source up-to-date company information
• Access a wealth of quality information on companies and key personnel.

Whether you are a product manager, in charge of marketing or simply interested to remain in touch with the latest developments in the Asian pharmaceutical industry, this Directory will save you time and effort in finding the up-to-date information you need.

For just US$350.00 The Asian Pharmaceutical Directory 2010 gives you instant access to a wealth of accurate information on thousands of companies.

Look at the depth of information you’ll get in The Asian Pharmaceutical Directory 2010:

• Company contact details.
• Telephone, Fax, Email and Web addresses.
• Names of key management and trading personnel.
• Product information.

6 Great reasons to order your copy of The Asian Pharmaceutical Directory:

1. Save time: no need to search the Internet, all the information you need is in one handy guide;
2. Save money: by using a resourceful book that details all your business contacts activities;
3. Gain an understanding of the key players in this increasingly dominant market: quickly and easily;
4. Source the right trader/producer: by identifying products quickly;
5. Discover new business leads: and grow your business;
6. Update your contact list: from the most reliable source in the industry.

Countries covered include: Australia, Bangladesh, Burma, Cambodia, China, India, Indonesia, Japan, Korea, Laos, Malaysia, New Zealand, Pakistan, the Philippines, Singapore, Sri Lanka, Taiwan, Thailand and Vietnam.

Why wait? If you’re are buying or selling pharmaceuticals in Asia, or wishing to do so, this directory is essential for you. Where else will you find such a broad depth of both key contact and production information for the Asian pharmaceutical industry in one handy reference source?

Improve your business prospects and invest in a copy TODAY!

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1163/Asian-Pharmaceutical-Directory-2010.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

The market potential of the African pharmaceutical and biotechnology sector is enormous and business opportunities abound. However, unraveling the maze of who’s who, and who does what is a daunting task. Here’s the solution you’ve been looking for.

This new edition of The African Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date guide to the African ever-changing pharmaceutical industry.

If you need to source from, or sell to Pharmaceuticals, Biotechnology products, Biopharmaceuticals, Bulk Pharmaceuticals, OTC/Healthcare products, Research & Development, Fine Chemicals, Generics, Genomics, or Diagnostics/Reagents; or, if you’re looking to break into this appealing market, the new African Pharmaceutical Directory will provide you with thousands of fresh business contacts – and help you keep track of old ones – quickly and easily.

This one directory covers the entire the African pharmaceutical & biotechnology industries sector.

This Directory will enable you to:

• Profile a market
• Build new business prospects
• Pinpoint key executives
• Generate new customers
• Discover who your competitors are
• Make vital contacts
• Save the time, money and effort of doing your own research
• Identify alternative suppliers and manufacturers
• Source up-to-date company information
• Access a wealth of quality information on companies and key personnel

Whether you are a product manager, in charge of marketing or simply interested to remain in touch with the latest developments in the African pharmaceutical industry, this Directory will save you time and effort in finding the up-to-date information you need.

For just US$150.00 The African Pharmaceutical Directory gives you instant access to a wealth of accurate information.

Look at the depth of information you’ll get in The African Pharmaceutical Directory

• Company contact details.
• Telephone, Fax, Email and Web addresses.
• Names of key management and trading personnel.
• Product information.

6 Great reasons to order your copy of The African Pharmaceutical Directory:

1. Save time: no need to search the Internet, all the information you need is in one handy guide;
2. Save money: by using a resourceful book that details all your business contacts activities;
3. Gain an understanding of the key players in this increasingly dominant market: quickly and easily;
4. Source the right trader/producer: by identifying products quickly;
5. Discover new business leads: and grow your business;
6. Update your contact list: from the most reliable source in the industry.

Why wait? If you’re are buying or selling pharmaceuticals in Africa, or wishing to do so, this directory is essential for you. Where else will you find such a broad depth of both key contact and production information for the African pharmaceutical industry in one handy reference source?

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1159/African-Pharmaceutical-Directory-2010.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

The latest research, “Pharmaceutical Pricing and Reimbursement – Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies” provides key data, information and analysis of the major issues affecting the pricing and reimbursement decisions across the globe. It discusses the major changes that have been observed in the pharmaceutical and healthcare industry at the global level. The report also covers issues specific to particular geographies. The geographies covered include the US and countries within Western Europe, Asia-Pacific, Central and Eastern Europe, and Scandinavia. It covers pricing and reimbursement mechanisms in different countries as well as the impact of issues on the key stakeholders. The report puts a special emphasis on orphan drugs since the pricing and reimbursement patterns for orphan drugs are different from the traditional mechanisms.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes :

- Identification and analysis of major issues that are affecting the pricing and reimbursement decisions across five different geographies. These include North America, Western Europe, Asia-Pacific, Central and Eastern Europe and Scandinavia
- Analysis of the issues and potential impact of pricing and reimbursement decisions on the key stakeholders
- Study of the pricing and reimbursement mechanisms in different countries and the identification of trends in the context of a particular geography as a whole
- Qualitative analysis of the forces that are driving and restraining the prices and reimbursements within a particular geography
- Future outlook of the pricing and reimbursement patterns for geographies under consideration

Reasons to buy

The report will enhance your decision making and will enable you to :

– Build understanding of the major issues in the pricing and reimbursement landscape
- Identify the impact of each issue on your business and develop solutions for adverse impacts
- Negotiate better with the government agencies to maximize the reimbursement on the drugs by understanding the pricing and reimbursement mechanism
- Develop effective business strategies for pricing a drug which is to be launched in any of the markets considered in this report
- Identify and exploit the factors that could help to maximize returns on the drugs for a particular geography in future

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1484/Pharmaceutical-Pricing-and-Reimbursement-Reference-Pricing-and-Economic-Evaluations-Will-Dominate-Future-Pricing-and-Reimbursement-Strategies.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

In recent years, China pharmaceutical logistics industry has changed fundamentally, which is reflected in the accomplished or ongoing logistics projects. Large-scale pharmaceutical distribution centers supported by T-bond discount loans have been founded and many small and medium-size pharmaceutical distribution centers are also under construction.

Pharmaceutical logistics is the result of the development of the pharmaceutical industry which is connected with pharmaceutical industry most closely. Market capacity and potential demand of pharmaceutical logistics industry can be reflected by those of pharmaceutical industry indirectly. Pharmaceutical industry is called as “”eternal sunrise industry”", mainly because of expanding market demand, which increasingly rely on the service offered by pharmaceutical logistics. Both of the demand for China pharmaceutical industry and that for China pharmaceutical logistics industry are driven by the following factors — economic growth, people’s awareness of self health care, aging population, urbanization, as well as health care system reform.

According to the latest data released by the National Bureau of Statistics of China in 2009, from January to May of 2009, China pharmaceutical manufacturing achieved the sales revenue of RMB321.988 billion, up 18.07% from the same period last year, but the growth rate was 11.36% lower than that of the same period last year. In 2008 around, China pharmaceutical manufacturing achieved the sales revenue of RMB825.36 billion, up 26.5% year-on-year. The average growth rate of China pharmaceutical manufacturing has been more than 20% over the past decade, far above the GDP growth rate in the same period. Chinese pharmaceutical logistics market has grown up fast with the development of pharmaceutical manufacturing.

In Chinese pharmaceutical market, a large number of pharmaceutical wholesale enterprises emerge and survive owing to China’s lack of macro-control policies and market access conditions, the isolation of drug regulation from drug operation, and local protection policies. As a result, in China pharmaceutical logistics industry, there are numerous small pharmaceutical enterprises which accounts for 90%; pharmaceutical enterprises have low intensity, low profit margins and low managerial efficiency; many enterprises produce considerable same products. At present, there are 16,500 wholesale pharmaceutical enterprises and 119,000 retail pharmaceutical enterprises in China, but the annual pharmaceutical sales revenue achieved by them only account for less than 10% of the global sales income. At the same time, the products often belong to the homogeneous varieties. 97% of chemicals produced in China are generic drugs. Innovation and research of new drugs are backward and the development of preparation progresses rather slow. Few innovative drugs exist.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1006/China-Pharmaceutical-Logistics-Industry-Report-2009.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 billion (30.35%) than RMB43.91 billion in 2007.

In 2008, the average profit margin of top 100 enterprises was 3.76%, more 0.76 points than that in 2007

The data of this report come from China Association of Pharmaceutical Commerce, www.pharmnet.com.cn, www.ydzz.com and the National Bureau of Statistics of China. The report makes an in-depth analysis of the operation and future development of pharmaceutical chain industry, guiding investment and financing decision-making.

This report includes 8 chapters and 65 diagrams, covering all major aspects and key enterprises in China pharmaceutical chain industry. Chapter 1 introduces the development of China pharmaceutical chain industry briefly. Chapter 2 analyzes the macroeconomic environment, industry environment and policies related with China pharmaceutical chain industry. Chapter 3, 4, 5 analyze operation, competition patterns and key areas of China pharmaceutical chain industry, such as market scale, profitability, competition patterns and regional difference. Chapter 6 analyzes the development trends of China pharmaceutical chain industry. Finally, Chapter 7 analyzes the development, revenue distribution and profitability of over 10 key Chinese pharmaceutical enterprises, including LBX Pharmacy, Nepstar, Hubei Tongjitang, Chongqing Tongjunge Pharmacy, Sinopharm Group Co., Ltd., Chongqing Peace Drugstore.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1022/China-Pharmaceutical-Chain-Industry-Report-2009.html

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com